Portfolio company Highlife Medical raised over $90M to start its US pivotal study and accelerate European commercial expansion.
HighLife Medical is dedicated to developing innovative treatment options for patients suffering from heart valve diseases, particularly focusing on Mitral Regurgitation
HighLife Medical is dedicated to developing innovative treatment options for patients suffering from heart valve diseases, particularly focusing on Mitral Regurgitation. The company has developed a transcatheter solution for mitral valve replacement that preserves the native valve structure.